echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nobigo® appeared at the 4th CIIE, innovating "Double Ge" to open a new decade of prostate cancer treatment

    Nobigo® appeared at the 4th CIIE, innovating "Double Ge" to open a new decade of prostate cancer treatment

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Shanghai, November 6, 2021/PRNewswire/ - On November 6, 2021, the special event "Health Life·Talking about the Prostate Cancer Patient Care Month and Nobigo® Appearance at the CIIE" will be the fourth The Bayer booth at the China International Import Expo was officially launched


    Mr.


    Mr.


    In recent years, the incidence of prostate cancer has been on the rise, and there are still unmet medical needs


    Prof.


    For mCRPC patients, cancer cells have spread beyond the prostate and are resistant to castration treatment (surgery or medication)


    Professor Zhu Yao, Department of Urology, Fudan University Cancer Hospital

    As the Chairman of Aipu Cancer Patient Care Foundation and Chairman of the Rehabilitation Branch of the Chinese Anti-Cancer Association, Shi Anli said, “This'Prostate Cancer Patient Care Month Special Event' brings together societies, experts, companies and other sources.


    About Bayer

    As a multinational company, Bayer has core competitiveness in health and agriculture in the field of life sciences


    Forward-looking statement

    This press release includes forward-looking statements made by the management of the Bayer Group based on current assumptions and forecasts


    Source: Bayer

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.